Ben Kasstan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ben Kasstan has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Sandra Mounier-Jack
Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK
6 shared publicationsTracey Chantler
Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, 15-17 Tavistock Place, London, WC1H 9SH, UK
6 shared publications- Tracey Chantler
London School of Hygiene & Tropical Medicine, London, UK
4 shared publications Vanessa Saliba
United Kingdom Health Security Agency, London Region, South Colonnade, Canary Wharf, London E14 4PU, United Kingdom
3 shared publicationsAna Zuriaga-Alvaro
The NHSE Legacy and Health Equity Partnership, NHS England, London, England, UK
2 shared publicationsHelen Bedford
Population, Policy and Practice Department, UCL Great Ormond Street Institute of Child Health, London, UK
2 shared publications
Latest Publications
- 18 September 2026
- Published by BMJ in Archives of Disease in Childhood
Addressing child poverty policy is central to improving vaccination coverage
Child poverty in England is higher than in comparable countries, and child health outcomes and childhood mortality rates have worsened since 2010.1 Child poverty rates in English local authorities increased by an average of 5.6% between 2015 and 2024, while first- and second-dose measles, mumps and rubella (MMR) uptake at 2 and 5 years declined by 4%–5%.2 Only 88.9% of children aged 2 years received their first MMR vaccination in 2024–2025, enabling sustained measles transmission and the UK’s loss of WHO measles …
- 18 September 2026
- Published by BMJ in Archives of Disease in Childhood
Addressing child poverty policy is central to improving vaccination coverage
Child poverty in England is higher than in comparable countries, and child health outcomes and childhood mortality rates have worsened since 2010.1 Child poverty rates in English local authorities increased by an average of 5.6% between 2015 and 2024, while first- and second-dose measles, mumps and rubella (MMR) uptake at 2 and 5 years declined by 4%–5%.2 Only 88.9% of children aged 2 years received their first MMR vaccination in 2024–2025, enabling sustained measles transmission and the UK’s loss of WHO measles …
- Open Access
- 9 February 2026
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 119 (3) , 69-72
Vaccination systems under pressure: what the UK COVID-19 Inquiry teaches us about preparedness
- 9 February 2026
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 119 (3) , 69-72
Open AccessVaccination systems under pressure: what the UK COVID-19 Inquiry teaches us about preparedness
- Open Access
- 11 August 2025
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 153, 1-4
Public health agencies need to be ‘Kennedy ready’: take action now to protect vaccine confidence
The Secretary of the US Department of Health & Human Services, Robert Kennedy Jr is leading a political agenda against vaccination. This is undermining the delivery of life-saving vaccination programmes and provision of evidence-based information on the safety and effectiveness of vaccines for the public and health professionals. Inconsistent and conflicting messaging between health practitioners and government health agencies erodes trust in public health programmes, creating a vacuum which is often filled with mis/disinformation that presents severe consequences for families. Due to the transnational spread of diseases, we consider the implications of events in the US for routine childhood vaccination programmes in the UK. Public health agencies across the world need to be ‘Kennedy ready’; pragmatic steps must be taken to mitigate threats posed to vaccine confidence and the control of vaccine preventable diseases.
- 11 August 2025
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 153, 1-4
Open AccessPublic health agencies need to be ‘Kennedy ready’: take action now to protect vaccine confidence
The Secretary of the US Department of Health & Human Services, Robert Kennedy Jr is leading a political agenda against vaccination. This is undermining the delivery of life-saving vaccination programmes and provision of evidence-based information on the safety and effectiveness of vaccines for the public and health professionals. Inconsistent and conflicting messaging between health practitioners and government health agencies erodes trust in public health programmes, creating a vacuum which is often filled with mis/disinformation that presents severe consequences for families. Due to the transnational spread of diseases, we consider the implications of events in the US for routine childhood vaccination programmes in the UK. Public health agencies across the world need to be ‘Kennedy ready’; pragmatic steps must be taken to mitigate threats posed to vaccine confidence and the control of vaccine preventable diseases.
- Open Access
- 2 January 2025
- Published by Taylor & Francis in Anthropology & Medicine
- Vol. 32 (1) , 1-6
Observing the observatory on race and health: reviewing ‘health communications with (and for) Jewish communities’
National Health Service England established the Race and Health Observatory as an independent expert body in 2021 to advance meaningful changes for Black and minority ethnic communities, patients, and healthcare professionals. It serves as a 'proactive investigator' by commissioning and facilitating research to achieve long-term transformation in health outcomes. However, medical anthropologists have largely overlooked the Observatory (and the research it commissions) in critical assessments of race and health. This commentary discusses the 2024 review into "health communications with (and for) Jewish communities" vis-à-vis the ethnographic record. On the one hand, the intention behind the Observatory's review is laudable because Jews have been excluded from critical discussions on race and health in the UK as well as the US and Europe. While the review has potential for rendering health inequality in Jewish communities visible, some of the overly general findings may lead to pitfalls and healthcare professionals may need additional guidance or support by establishing diverse steering groups. This comment argues that observing the Observatory on Race and Health is important to ensure accountability over its research and recommendations, and from a conceptual standpoint, to examine the evolving apparatus that shapes public and political reckonings with race, ethnicity and in/equality.
- 2 January 2025
- Published by Taylor & Francis in Anthropology & Medicine
- Vol. 32 (1) , 1-6
Open AccessObserving the observatory on race and health: reviewing ‘health communications with (and for) Jewish communities’
National Health Service England established the Race and Health Observatory as an independent expert body in 2021 to advance meaningful changes for Black and minority ethnic communities, patients, and healthcare professionals. It serves as a 'proactive investigator' by commissioning and facilitating research to achieve long-term transformation in health outcomes. However, medical anthropologists have largely overlooked the Observatory (and the research it commissions) in critical assessments of race and health. This commentary discusses the 2024 review into "health communications with (and for) Jewish communities" vis-à-vis the ethnographic record. On the one hand, the intention behind the Observatory's review is laudable because Jews have been excluded from critical discussions on race and health in the UK as well as the US and Europe. While the review has potential for rendering health inequality in Jewish communities visible, some of the overly general findings may lead to pitfalls and healthcare professionals may need additional guidance or support by establishing diverse steering groups. This comment argues that observing the Observatory on Race and Health is important to ensure accountability over its research and recommendations, and from a conceptual standpoint, to examine the evolving apparatus that shapes public and political reckonings with race, ethnicity and in/equality.
- Open Access
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e001889
Qualitative evaluation of two London Faith and Health Networks: lessons learnt from a model of an interface between health systems and minority communities
Background: Ethnic and religious minorities in the UK had a higher risk of severe illness and mortality from COVID-19 in 2020–2021, yet were less likely to receive vaccinations. Two Faith Health Networks (FHNs) were established in London in 2022–2024 as a partnership approach to mitigate health inequalities among Muslim and Jewish Londoners through a health system–community collaboration. By evaluating the FHNs, this study aimed to examine: the organisational processes required for FHNs to serve as a model of interface between health systems and minority communities; the role these networks play in addressing public health inequalities; and implications for their future development and sustainability. Methods: A qualitative evaluation of the two FHNs was conducted using semi-structured interviews (n=19) with members of the ‘London Jewish Health Partnership’ and the ‘London Muslim Health Network’. Participant clusters included public health professionals, healthcare workers, community representatives and local government workers. Results: The FHNs shared similar structures of leadership, but differed in core membership, which influenced their access to expertise and the activities developed. They were found to perform a key conduit role by integrating expertise from within the health system and faith communities to address the needs and expectations of underserved communities, with the ultimate goal of addressing health inequalities through the design of tailored campaigns and services. Emerging themes for developing an FHN model included enhancing their sustainability by determining funding allocation, strategic integration into health systems and identifying the appropriate geographical scope to sustain their impact. Further implications included recognition of intersectionality, addressing diverse needs within faith communities and trust-building approaches. Conclusion: This evaluation offers insights into developing partnership models between faith-based organisations and health sectors to foster relationships with underserved communities. These findings provide valuable considerations for teams navigating the priority of health equity and community engagement as part of our learning from the pandemic to support the development of FHNs across different faith communities, not just for vaccine uptake, but to support the broader health and well-being of communities more widely.
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e001889
Open AccessQualitative evaluation of two London Faith and Health Networks: lessons learnt from a model of an interface between health systems and minority communities
Background: Ethnic and religious minorities in the UK had a higher risk of severe illness and mortality from COVID-19 in 2020–2021, yet were less likely to receive vaccinations. Two Faith Health Networks (FHNs) were established in London in 2022–2024 as a partnership approach to mitigate health inequalities among Muslim and Jewish Londoners through a health system–community collaboration. By evaluating the FHNs, this study aimed to examine: the organisational processes required for FHNs to serve as a model of interface between health systems and minority communities; the role these networks play in addressing public health inequalities; and implications for their future development and sustainability. Methods: A qualitative evaluation of the two FHNs was conducted using semi-structured interviews (n=19) with members of the ‘London Jewish Health Partnership’ and the ‘London Muslim Health Network’. Participant clusters included public health professionals, healthcare workers, community representatives and local government workers. Results: The FHNs shared similar structures of leadership, but differed in core membership, which influenced their access to expertise and the activities developed. They were found to perform a key conduit role by integrating expertise from within the health system and faith communities to address the needs and expectations of underserved communities, with the ultimate goal of addressing health inequalities through the design of tailored campaigns and services. Emerging themes for developing an FHN model included enhancing their sustainability by determining funding allocation, strategic integration into health systems and identifying the appropriate geographical scope to sustain their impact. Further implications included recognition of intersectionality, addressing diverse needs within faith communities and trust-building approaches. Conclusion: This evaluation offers insights into developing partnership models between faith-based organisations and health sectors to foster relationships with underserved communities. These findings provide valuable considerations for teams navigating the priority of health equity and community engagement as part of our learning from the pandemic to support the development of FHNs across different faith communities, not just for vaccine uptake, but to support the broader health and well-being of communities more widely.
- Open Access
- 10 August 2024
- Published by Elsevier in Social Science & Medicine
- Vol. 357, 117196
Polio, public health memories and temporal dissonance of re-emerging infectious diseases in the global north
- 10 August 2024
- Published by Elsevier in Social Science & Medicine
- Vol. 357, 117196
Open AccessPolio, public health memories and temporal dissonance of re-emerging infectious diseases in the global north
- Open Access
- 28 June 2024
- Published by BMJ in BMJ Public Health
- Vol. 2 (1) , e000929
Improving influenza vaccine uptake in clinical risk groups: patient, provider and commissioner perspectives on the acceptability and feasibility of expanding delivery pathways in England
Background: People under the age of 65 in clinical risk groups are at increased risk of severe complications and death from influenza. In England, influenza vaccine coverage rates in this cohort remain profoundly low. This qualitative study aimed to explore (1) the reasons that underly suboptimal influenza vaccine uptake among different clinical risk groups in England and (2) how healthcare providers and commissioners perceive the feasibility and acceptability of integrating the influenza vaccine programme in non-primary care settings. Methods: The study consisted of two phases. Phase I involved 32 semi-structured interviews conducted with individuals from three clinical risk groups: diabetes, chronic liver disease or chronic respiratory disease (or comorbidities). Phase II consisted of semi-structured interviews with 50 healthcare providers based in National Health Service primary and secondary care settings, and influenza vaccine commissioners and programme managers. Data were analysed thematically. Results: Access was not the primary issue underlying suboptimal vaccine uptake among participants in clinical risk groups, who instead cited low-risk perceptions of influenza infection and deficits of information about the relevance of vaccination for their condition management. Healthcare providers in non-primary care settings rarely discussed or recommended influenza vaccination across patient pathways, despite being able to address the concerns raised by participants in clinical risk groups. Healthcare providers were positive about the potential to offer vaccine recommendations and delivery, but questions remain around feasibility. Conclusion: Patient pathways are punctuated with varying opportunities to discuss or deliver influenza vaccines during the winter season, though the commissioning and organisation of chronic disease management shapes how clinical risk groups interface with primary/secondary tiers of healthcare services. Embedding vaccine delivery in non-primary care settings may help to reduce inequalities and offer patients at risk the information and consent pathways they desire but is not a cost-neutral innovation and requires resource allocation.
- 28 June 2024
- Published by BMJ in BMJ Public Health
- Vol. 2 (1) , e000929
Open AccessImproving influenza vaccine uptake in clinical risk groups: patient, provider and commissioner perspectives on the acceptability and feasibility of expanding delivery pathways in England
Background: People under the age of 65 in clinical risk groups are at increased risk of severe complications and death from influenza. In England, influenza vaccine coverage rates in this cohort remain profoundly low. This qualitative study aimed to explore (1) the reasons that underly suboptimal influenza vaccine uptake among different clinical risk groups in England and (2) how healthcare providers and commissioners perceive the feasibility and acceptability of integrating the influenza vaccine programme in non-primary care settings. Methods: The study consisted of two phases. Phase I involved 32 semi-structured interviews conducted with individuals from three clinical risk groups: diabetes, chronic liver disease or chronic respiratory disease (or comorbidities). Phase II consisted of semi-structured interviews with 50 healthcare providers based in National Health Service primary and secondary care settings, and influenza vaccine commissioners and programme managers. Data were analysed thematically. Results: Access was not the primary issue underlying suboptimal vaccine uptake among participants in clinical risk groups, who instead cited low-risk perceptions of influenza infection and deficits of information about the relevance of vaccination for their condition management. Healthcare providers in non-primary care settings rarely discussed or recommended influenza vaccination across patient pathways, despite being able to address the concerns raised by participants in clinical risk groups. Healthcare providers were positive about the potential to offer vaccine recommendations and delivery, but questions remain around feasibility. Conclusion: Patient pathways are punctuated with varying opportunities to discuss or deliver influenza vaccines during the winter season, though the commissioning and organisation of chronic disease management shapes how clinical risk groups interface with primary/secondary tiers of healthcare services. Embedding vaccine delivery in non-primary care settings may help to reduce inequalities and offer patients at risk the information and consent pathways they desire but is not a cost-neutral innovation and requires resource allocation.
- Open Access
- 2 November 2023
- Published by Elsevier in SSM - Qualitative Research in Health
- Vol. 4, 100365
“We're potentially worsening health inequalities”: Evaluating how delivery of the 2022 London polio booster campaign was tailored to Orthodox Jewish families to reduce transmission vulnerability
- 2 November 2023
- Published by Elsevier in SSM - Qualitative Research in Health
- Vol. 4, 100365
Open Access“We're potentially worsening health inequalities”: Evaluating how delivery of the 2022 London polio booster campaign was tailored to Orthodox Jewish families to reduce transmission vulnerability
- Open Access
- 12 July 2023
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 151, 1-25
Poliovirus outbreak in New York State, August 2022: qualitative assessment of immediate public health responses and priorities for improving vaccine coverage
In 2022, a case of paralysis was reported in an unvaccinated adult in Rockland County (RC), New York. Genetically linked detections of vaccine-derived poliovirus type 2 (VDPV2) were reported in multiple New York counties, England, Israel, and Canada. The aims of this qualitative study were to: i) review immediate public health responses in New York to assess the challenges in addressing gaps in vaccination coverage; ii) inform a longer-term strategy to improving vaccination coverage in under-vaccinated communities, and iii) collect data to support comparative evaluations of transnational poliovirus outbreaks. Twenty-three semi-structured interviews were conducted with public health professionals, healthcare professionals, and community partners. Results indicate that i) addressing suboptimal vaccination coverage in RC remains a significant challenge after recent disease outbreaks; ii) the poliovirus outbreak was not unexpected and effort should be invested to engage mothers, the key decision-makers on childhood vaccination; iii) healthcare providers (especially paediatricians) received technical support during the outbreak, and may require resources and guidance to effectively contribute to longer-term vaccine engagement strategies; vi) data systems strengthening is required to help track under-vaccinated children. Public health departments should prioritize long-term investments in appropriate communication strategies, countering misinformation, and promoting the importance of the routine immunization schedule.
- 12 July 2023
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 151, 1-25
Open AccessPoliovirus outbreak in New York State, August 2022: qualitative assessment of immediate public health responses and priorities for improving vaccine coverage
In 2022, a case of paralysis was reported in an unvaccinated adult in Rockland County (RC), New York. Genetically linked detections of vaccine-derived poliovirus type 2 (VDPV2) were reported in multiple New York counties, England, Israel, and Canada. The aims of this qualitative study were to: i) review immediate public health responses in New York to assess the challenges in addressing gaps in vaccination coverage; ii) inform a longer-term strategy to improving vaccination coverage in under-vaccinated communities, and iii) collect data to support comparative evaluations of transnational poliovirus outbreaks. Twenty-three semi-structured interviews were conducted with public health professionals, healthcare professionals, and community partners. Results indicate that i) addressing suboptimal vaccination coverage in RC remains a significant challenge after recent disease outbreaks; ii) the poliovirus outbreak was not unexpected and effort should be invested to engage mothers, the key decision-makers on childhood vaccination; iii) healthcare providers (especially paediatricians) received technical support during the outbreak, and may require resources and guidance to effectively contribute to longer-term vaccine engagement strategies; vi) data systems strengthening is required to help track under-vaccinated children. Public health departments should prioritize long-term investments in appropriate communication strategies, countering misinformation, and promoting the importance of the routine immunization schedule.